MESOPORÖSES ELASTOMER

European patent · EP3802677 · In force

Register entry

Publication number
EP3802677
Application number
EP19717986
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 8, 2019
Published
Apr 14, 2021
Granted
Apr 17, 2024
Protection ends at the latest
Apr 7, 2039
Next annual fee due
Apr 30, 2027
IPC classes
C08J 9/28 (2006.01)
C08G 65/32 (2006.01)
A61K 9/14 (2006.01)
A61K 47/69 (2017.01)
Priority
US 201862676391 P 25.05.2018
PCT application
PCT/SE2019/050320 08.04.2019
PCT publication
WO2019/226086 28.11.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. Feb 26, 2025

    Change

    Published in Swissreg on 26.02.2025

  4. May 14, 2024

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 14.05.2024

  5. Apr 17, 2024

    Granted

    Published in Swissreg on 17.04.2024

Parties

Holder

Amferia AB

AZ BioVenturehub c/o AstraZeneca Pepparedsleden 1, 43183 Mölndal, SE

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

ANDERSSON, Martin

431 38 MÖLNDAL, SE

RAJASEKHARAN, Anand Kumar

412 60 GÖTEBORG, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.